Long-term NSAID use may lower dementia risk

FHS
March 9, 2025
11:23 pm

Long-term NSAID use reduces dementia risk, particularly in those without the APOE-ε4 gene, highlighting the importance of sustained anti-inflammatory treatment over dosage levels.

Urgent strategies needed to fight artemisinin resistance in East Africa

Artemisinin-based combination therapies (ACTs) have become the cornerstone of malaria treatment and control.

July 19, 2024

Malaria cases in Florida and Texas: Here’s what you need to know

The five cases of malaria diagnosed in Florida and Texas in recent weeks — the first cases of local transmission in the United States in

June 30, 2023

Faricimab vs Aflibercept in Diabetic Macular Edema

Intraretinal hyperreflective foci, intraretinal hard exudates, and epiretinal membrane formation were lower after treatment with faricimab (Vabysmo) compared with aflibercept (Eylea) for patients with diabetic

November 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.